6426 - 6450 of 8617 Results
Title
Year
-
RESTRICTEDTitle: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abj2658Citation Count: 163
- Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants2022OPENTitle: Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein VariantsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1790End Page: 1804Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00190Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00190Citation Count: 4
-
OPENTitle: Untwisted α-Synuclein Filaments Formed in the Presence of Lipid VesiclesJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 61Issue #: 17Start Page: 1766End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.biochem.2c00283Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10289115Citation Count: 9
- Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease2022RESTRICTEDTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 16
-
OPENTitle: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 PandemicJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 9Start Page: 801End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2022.1510Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2789055/jama_suran_2022_mn_220006_1645750114.50702.pdfCitation Count: 6
- Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review2023OPENTitle: Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart reviewJournal Name: Epilepsia OpenPublisher: WileyVol: 8Issue #: 2Start Page: 371End Page: 385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12695Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/epi4.12695Citation Count: 7
-
OPENTitle: The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 4Start Page: 596End Page: 605Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13678Best OA location URL: https://escholarship.org/content/qt2wb861nd/qt2wb861nd.pdfCitation Count: 1
- Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease2023OPENTitle: Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 896End Page: 902Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13726Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13726Citation Count: 1
-
OPENTitle: Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 933End Page: 942Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13747Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10272891Citation Count: 1
- Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging2021OPENTitle: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on AgingJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 18Issue #: 2Start Page: 345End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.9562Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8804990Citation Count: 10
- Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairment2023OPENTitle: Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairmentJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00531-yBest OA location URL: https://www.nature.com/articles/s41531-023-00531-y.pdfCitation Count: 20
-
OPENTitle: Unveiling the B cell receptor structureJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 819End Page: 820Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add8065Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11044948Citation Count: 10
- Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma2022OPENTitle: Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in OsteosarcomaJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 21Issue #: 6Start Page: 903End Page: 913Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1158/1535-7163.mct-21-0836Best OA location URL: https://aacrjournals.org/mct/article-pdf/21/6/903/3191485/903.pdfCitation Count: 26
- Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progression2020OPENTitle: Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 7Start Page: 965End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.12083Best OA location URL: https://doi.org/10.1002/alz.12083Citation Count: 47
-
OPENTitle: Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 2Start Page: 335End Page: 344Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.201Best OA location URL: https://escholarship.org/content/qt7k74z129/qt7k74z129.pdfCitation Count: 98
- Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease2020OPENTitle: Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 5Start Page: 831End Page: 846Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12240Best OA location URL: https://doi.org/10.1002/alz.12240Citation Count: 16
- Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiology2020OPENTitle: Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 3Start Page: 489End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12211Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12211Citation Count: 28
- Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer’s disease risk in humans2020OPENTitle: Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer’s disease risk in humansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.043533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.043533Citation Count: 6
- Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases2020OPENTitle: Genetic screening of a large series of North American sporadic and familial frontotemporal dementia casesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 118End Page: 130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7199807Citation Count: 63
-
OPENTitle: Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 91End Page: 105Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12001Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12001Citation Count: 40
- New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures2019OPENTitle: New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measuresJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 131End Page: 143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2019.06.4956Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6949386Citation Count: 53
- Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration2019OPENTitle: Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 37End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2019.04.007Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.04.007Citation Count: 39
-
OPENTitle: Cerebrovascular medin is associated with Alzheimer's disease and vascular dementiaJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12072Best OA location URL: https://doi.org/10.1002/dad2.12072Citation Count: 20
-
OPENTitle: Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes NeurotoxicJournal Name: Angewandte ChemiePublisher: WileyVol: 133Issue #: 17Start Page: 9299End Page: 9330Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ange.202000451Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202000451Citation Count: 12
-
OPENTitle: Non‐coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in womenJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 2Start Page: 215End Page: 225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12181Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7920533Citation Count: 28